• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾酮替代疗法对促黄体生成素释放激素激动剂抑制精子生成的影响。

Influence of testosterone substitution on sperm suppression by LHRH agonists.

作者信息

Bouchard P, Garcia E

机构信息

Service d'Endocrinologie et des Maladies de la Reproduction, Hôpital de Bicêtre, Le Kremlin, France.

出版信息

Horm Res. 1987;28(2-4):175-80. doi: 10.1159/000180942.

DOI:10.1159/000180942
PMID:2969861
Abstract

To investigate the effect of LHRH (GnRH) agonists on sperm suppression, we studied the effect of a depot preparation of D-Trp6 LHRH in 10 normal men for 30 weeks. In addition, to determine the role of androgenic substitution on sperm suppression, the volunteers were divided into two groups: group 1 (n = 5) received a low dose T substitution (125 mg of T enanthate every month), while group 2 (n = 5) received a normal T substitution (120 mg of T undecanoate every day). Four men became azoospermic in group 1 and none in group 2. Moreover, administration of additional T injections in 1 volunteer of group 1 resulted in the reappearance of spermatozoa in the ejaculate. Return to the low dose therapy produced azoospermia. These results suggest that testosterone supplementation supports spermatogenesis.

摘要

为研究促黄体生成素释放激素(LHRH,即GnRH)激动剂对精子抑制的作用,我们对10名正常男性使用长效D-色氨酸6-LHRH制剂进行了为期30周的研究。此外,为确定雄激素替代在精子抑制中的作用,志愿者被分为两组:第1组(n = 5)接受低剂量睾酮替代治疗(每月125mg庚酸睾酮),而第2组(n = 5)接受正常剂量睾酮替代治疗(每天120mg十一酸睾酮)。第1组中有4名男性出现无精子症,第2组中无人出现。此外,第1组的1名志愿者额外注射睾酮后,射精中再次出现精子。恢复低剂量治疗则导致无精子症。这些结果表明,补充睾酮可支持精子发生。

相似文献

1
Influence of testosterone substitution on sperm suppression by LHRH agonists.睾酮替代疗法对促黄体生成素释放激素激动剂抑制精子生成的影响。
Horm Res. 1987;28(2-4):175-80. doi: 10.1159/000180942.
2
Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.确定长效睾酮制剂中长效孕激素抑制人类精子发生的最小有效剂量及相加作用。
J Clin Endocrinol Metab. 1996 Nov;81(11):4113-21. doi: 10.1210/jcem.81.11.8923869.
3
Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.促性腺激素释放激素拮抗剂联合睾酮(T)与单独使用T作为潜在男性避孕方案的比较。
J Clin Endocrinol Metab. 1993 Aug;77(2):427-32. doi: 10.1210/jcem.77.2.8345047.
4
Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.男性避孕研究中庚酸睾酮诱导无精子症与少精子症的比较。I:血浆促黄体生成素、促卵泡生成素、睾酮、雌二醇和抑制素浓度。
J Clin Endocrinol Metab. 1993 Jul;77(1):290-3. doi: 10.1210/jcem.77.1.8325955.
5
Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.在一项男性避孕临床试验中,长效促性腺激素释放激素激动剂可减弱雄激素诱导的精子发生抑制作用。
J Clin Endocrinol Metab. 1992 Jan;74(1):84-90. doi: 10.1210/jcem.74.1.1727833.
6
Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation.使用促性腺激素释放激素拮抗剂抑制精子发生并补充睾酮后的精子运动参数。
Fertil Steril. 1993 Jun;59(6):1261-5.
7
Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.正常男性长期使用睾酮的效果:高剂量睾酮的安全性和有效性以及黄体生成素、卵泡刺激素和精子生成的平行剂量依赖性抑制
J Clin Endocrinol Metab. 1990 Jan;70(1):282-7. doi: 10.1210/jcem-70-1-282.
8
Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.联合使用那法瑞林-谷氨酸促性腺激素释放激素拮抗剂和庚酸睾酮诱导正常男性无精子症
J Clin Endocrinol Metab. 1992 Aug;75(2):476-83. doi: 10.1210/jcem.75.2.1639948.
9
Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.布西睾酮用于男性避孕的潜力:反应者与无反应者之间的内分泌差异
J Clin Endocrinol Metab. 1995 Aug;80(8):2394-403. doi: 10.1210/jcem.80.8.7543113.
10
Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.使用口服孕激素与经皮或口服雄激素的不同组合抑制男性精子发生。
Int J Androl. 1988 Jun;11(3):187-99. doi: 10.1111/j.1365-2605.1988.tb00994.x.

引用本文的文献

1
Hormonal, chemical and thermal inhibition of spermatogenesis: contribution of French teams to international data with the aim of developing male contraception in France.激素、化学和热对精子发生的抑制作用:法国团队对国际数据的贡献,旨在推动法国的男性避孕研究。
Basic Clin Androl. 2017 Jan 13;27:3. doi: 10.1186/s12610-016-0047-2. eCollection 2017.
2
FDA-approved medications that impair human spermatogenesis.经美国食品药品监督管理局批准的会损害人类精子发生的药物。
Oncotarget. 2017 Feb 7;8(6):10714-10725. doi: 10.18632/oncotarget.12956.